English Overview
Timely diagnosis of Alzheimer’s disease remains a challenge, with many cases identified only at advanced symptomatic stages and specialist resources often stretched thin.
This Activity for
- Resident / Fellow
- Physician
What I will learn?
This event aims to improve the Alzheimer’s disease diagnostic pathway by highlighting digital cognitive assessment tools and blood-based biomarkers as innovative approaches for earlier and more efficient patient identification, starting at the primary care level and facilitating timely referral to specialist care. The session will focus on the adoption, practical use, and expected outcomes of digital cognitive assessment tools, as well as the implementation of high-performing blood-based biomarkers and guidance on interpreting results to support clinical decision-making.
